Severe myoclonic epilepsy in infancy (SMEI) is a rare disease, characterized by febrile and
afebrile, generalized and unilateral, clonic or tonic–clonic seizures that occur in the first year�…

To report the authors' experience with diagnosis and management of Dravet syndrome, or
severe myoclonic epilepsy in infancy, in the era of commercially available genetic testing�…

Severe myoclonic epilepsy of infancy (SMEI) is a complex form of epilepsy that was first
described in France in 1978. Because the myoclonic component of this epilepsy is not�…

Severe Myoclonic Epilepsy in infancy (SMEI, or Dravet syndrome) is a drug‐resistant
epilepsy that occurs in the first year of life of previously healthy children. The main clinical�…

Severe myoclonic epilepsy in infancy (SME) was described by Dravet in 1978 (1). In 1992,
there were at least 192 published cases (2). At present, it is more difficult to give a precise�…

Dravet syndrome, or as it was called in the past 'severe myoclonic epilepsy in infancy', is a
drug‐resistant epilepsy first described by Charlotte Dravet in 1978. Besides the well‐known�…

Dravet syndrome (DS), previously known as severe myoclonic epilepsy in infancy (SMEI), is
an epileptic encephalopathy that presents with prolonged seizures in the first year of life�…

Severe myoclonic epilepsy of infancy (SMEI or Dravet syndrome) is a rare disorder occurring
in young children often without a family history of a similar disorder. The earliest disease�…

Background Severe myoclonic epilepsy of infancy (SMEI) or Dravet syndrome has been
long suspected of having a genetic origin. Recently, mutations in SCN1A and GABRG2 have�…

Dravet syndrome (DS), also known as severe myoclonic epilepsy of infancy (SMEI), is one of
the rare early childhood intractable epileptic encephalopathies associated with pleomorphic�…